1.Myocardial protective effect of dexmedetomidine during non-cardiac surgery in patients with coronary heart disease
Lirong GONG ; Jianbo YU ; Yuan ZHANG ; Man WANG ; Baolai GAO ; Zhixue LIU ; Lanfang ZHANG
Chinese Journal of Anesthesiology 2011;31(2):160-162
Objective To evaluate the myocardial protective effect of dexmedetomidine during non-cardiac surgery in patients with coronary heart disease.Methods Eighty ASAⅡor Ⅲ patients with coronary heat disease (NYHA Ⅱ or Ⅲ)aged 43-76 yr weighing 52-80 kg scheduled for elective upper abdominal surgery were randomly divided into 2 groups(n=40 each):control group(group C)and dexmedetomidine group(group D).Anesthesia was induced with etomidate 0.25 mg/kg,sufentanil 0.5 μg/kg and vecuronium 0.1 mg/kg.The patients were tracheal intubated and mechanically ventilated.A loading dose of dexmedetomidine 1μg/kg was injected intravenously 10 min before induction followed by infusion at 0.4 μg·kg-1·h-1 until the end of operation in group D.While equal volume of normal saline was given in group C.BIS was maintained at 40-49.Blood samples were taken before induction and at the end of operation for determination of serum concenlrations of IL-6,TNF-α,cardiac troponin Ⅰ(cTnI)and glycogen phosphorylase BB(GP-BB).The adverse cardiovascular events were recorded during operation.Results The serum concentrations of IL-6,TNF-α,cTnI and GP-BB and incidences of tachycardia and myocardial ischemia were significantly lower,while the incidences of bradycardia highcr in group D than in group C (P<0.05).Conclusion Dexmedetomidine Can exert the myocardial protective effect during non-cardiac surgery in patients with coronary heart disease and the mechanism may be related to the inhibition of the release of pro-inflammatory cytokines.
2.A comparative study of targeting drug magnetic nanoparticles and other chemotherapy drugs on human cholangiocarcinoma xenografts
Tao TANG ; Jianwei ZHENG ; Hong LI ; Baolai XIAO ; Bo CHEN ; Gao LI ; Shuai XU ; Shengquan ZHOU ; Xing AI ; Xi LI
Chinese Journal of General Surgery 1993;0(02):-
Objective To study the effect of magnetic nanoparticles on human cholangiocarcinoma xenograft in nude mice, and compared with otherchemotherapy drugs Methods We established human cholangiocarcinoma xenograft in nude mice with QBC939 cell line.The nude mice were devided into 4 groups randomly.Saline,5-FU, Gemcitabine and magnetic nanoparticles were given to nude mice through tail vein on 20d after implanting QBC939 cell line. Calculations were done at different time after treatment in order to compare tumor volume,inhibition ratio of tumor and tumor growth curve of each group. The nude mice were killed on 35d after treatment to harvest tissue for electron microscopic examination to observe ultra-structural changes. Results The tumor volume of control, 5-FU, magnetic nanoparticles and Gemcitabine groups was (2256.1?267.1) mm3, (2096.5?237.9)mm3,(1392.2?189)mm3, and (1534.9?115 )mm3 respectively.The last two groups have significant difference compared to the first two groups(P